Progressive Cone‐Rod Synaptic Dysfunction in Dynamin‐1 ( DNM1 ) Related Developmental and Epileptic Encephalopathy: A Distinct Retinal Phenotype in Human
Clinical Genetics · 2025
DOI: 10.1111/cge.14724 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Genetics, 2025. Verfasst von Oliver R Marmoy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Academic Department of Ophthalmology, Great Ormond Street Hospital for Children, London, UK. Hauptthemen laut MEDLINE: Dynamin I, Epilepsy. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dynamin‐1 is an essential enzyme involved in the recycling of synaptic vesicles, in particular in the scission of endocytic buds within the pre‐synaptic terminal. Heterozygous pathogenic variants in DNM1 result in Developmental and Epileptic Encephalopathy type 31A, where patients exhibit early onset refractory epilepsy, severe‐profound intellectual disability and poor visual behaviour. We present data demonstrating that this disorder progressively affects retinal synaptic function which, to our knowledge, is the first report of this phenotype in human. Clinical notes of the proband were reviewed incorporating ophthalmic phenotyping (imaging, electroretinography (ERG), pattern visual evoked potentials (PVEPs) and visual symptoms). Genetic testing was performed using trio whole genome sequencing. Genetic testing confirmed a de‐novo pathogenic variant in DNM1 , a recurrent heterozygous missense variant, c.709C > T;p.(Arg237Trp). Serial ERG testing at 1, 3, 9 and 12 years old indicated a progressive inner retinal dysfunction affecting both rod and cone synaptic pathways mirroring the abnormalities in the mouse model of dnm1, with normal retinal structure. DNM1 affects retinal synaptic recycling and endocytosis and our findings show likely usefulness of ERG testing in affected individuals. Further work is needed to expand our understanding of how different DNM1 variants affect retinal function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Academic Department of Ophthalmology, Great Ormond Street Hospital for Children, London, UK.
- UCL-GOS Institute of Child Health, London, UK.
- Department of Clinical Genetics, Great Ormond Street Hospital, London, UK.
- International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK.
ORCID-Profile: Oliver R Marmoy
Zitieren
APA
Marmoy, O. R., Hay, E., Bowman, R., & Thompson, D. A. (2025). Progressive Cone‐Rod Synaptic Dysfunction in Dynamin‐1 ( DNM1 ) Related Developmental and Epileptic Encephalopathy: A Distinct Retinal Phenotype in Human. Clinical Genetics. https://doi.org/10.1111/cge.14724
Vancouver
Marmoy OR, Hay E, Bowman R, Thompson DA. Progressive Cone‐Rod Synaptic Dysfunction in Dynamin‐1 ( DNM1 ) Related Developmental and Epileptic Encephalopathy: A Distinct Retinal Phenotype in Human. Clinical Genetics. 2025. doi:10.1111/cge.14724
BibTeX
@article{Marmoy2025,
author = {Marmoy, Oliver R and Hay, Eleanor and Bowman, Richard and Thompson, Dorothy A},
title = {Progressive Cone‐Rod Synaptic Dysfunction in Dynamin‐1 ( DNM1 ) Related Developmental and Epileptic Encephalopathy: A Distinct Retinal Phenotype in Human},
journal = {Clinical Genetics},
year = {2025},
doi = {10.1111/cge.14724}
}
EUVIMED